Advertisement

Index by Author

December 1999; 22 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adèr, H J

    • The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care December 1999 22:2004-2010; doi:10.2337/diacare.22.12.2004

  2. Aharon, Y

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  3. Akerblom, H K

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950
    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

  4. Albertini, J P

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

  5. Altman, J J

    • Safety of human insulin in poor-sighted elderly diabetic patients. Diabetes Care December 1999 22:2089; doi:10.2337/diacare.22.12.2089b

  6. Anderson, C M

    • Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care December 1999 22:2095-2096; doi:10.2337/diacare.22.12.2095

  7. Anderson, R M

    • In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care December 1999 22:2090-2092; doi:10.2337/diacare.22.12.2090

  8. Asplund, K

    • Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care December 1999 22:1988-1992; doi:10.2337/diacare.22.12.1988

  9. Atkinson, A B

    • Relationship of endothelial function to birth weight in humans. Diabetes Care December 1999 22:2061-2066; doi:10.2337/diacare.22.12.2061

  10. Attali, J R

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

B

  1. Bald, E

    • Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care December 1999 22:2097-2099; doi:10.2337/diacare.22.12.2097

  2. Belicar, P

    • Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs. Diabetes Care December 1999 22:2089-2090; doi:10.2337/diacare.22.12.2089a

  3. Berntorp, E

    • Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care December 1999 22:1944-1949; doi:10.2337/diacare.22.12.1944

  4. Berntorp, K

    • Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care December 1999 22:1944-1949; doi:10.2337/diacare.22.12.1944

  5. Bhattacharyya, A

    • Insulin lispro, pregnancy, and retinopathy. Diabetes Care December 1999 22:2101-2104; doi:10.2337/diacare.22.12.2101

  6. Bingley, P J

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  7. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1999. New approaches to insulin treatment and glucose monitoring. Diabetes Care December 1999 22:2078-2082; doi:10.2337/diacare.22.12.2078

  8. Boemi, M

    • Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients. Diabetes Care December 1999 22:2033-2036; doi:10.2337/diacare.22.12.2033

  9. Boivin, S

    • Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs. Diabetes Care December 1999 22:2089-2090; doi:10.2337/diacare.22.12.2089a

  10. Bonnemaire, M

    • Safety of human insulin in poor-sighted elderly diabetic patients. Diabetes Care December 1999 22:2089; doi:10.2337/diacare.22.12.2089b

  11. Bortolotti, N

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  12. Bo, S

    • Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes. Diabetes Care December 1999 22:2092; doi:10.2337/diacare.22.12.2092b

  13. Bottazzo, G F

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  14. Bryden, K S

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

  15. Burge, M R

    • Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care December 1999 22:2037-2043; doi:10.2337/diacare.22.12.2037

C

  1. Calmar, S

    • Safety of human insulin in poor-sighted elderly diabetic patients. Diabetes Care December 1999 22:2089; doi:10.2337/diacare.22.12.2089b

  2. Catone, B

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  3. Cavallo-Perin, P

    • Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes. Diabetes Care December 1999 22:2092; doi:10.2337/diacare.22.12.2092b

  4. Ceriello, A

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  5. Chang, C J

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

  6. Chan, J C

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  7. Cheung, A Y

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  8. Chiu, N T

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

  9. Chow, C C

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  10. Chwatko, G

    • Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care December 1999 22:2097-2099; doi:10.2337/diacare.22.12.2097

  11. Clarke, W L

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

  12. Cockram, C S

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  13. Cogswell, M E

    • Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care December 1999 22:1978-1983; doi:10.2337/diacare.22.12.1978

  14. Colwell, G A

    • Inflammation and diabetic vascular complications. Diabetes Care December 1999 22:1927-1928; doi:10.2337/diacare.22.12.1927

  15. Corcoy, R

    • Benzodiazepine interruption. Does it cause hypoglycemia? Diabetes Care December 1999 22:2099; doi:10.2337/diacare.22.12.2099b

  16. Costa, M

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  17. Couper, J J

    • Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care December 1999 22:1933-1937; doi:10.2337/diacare.22.12.1933

  18. Cox, D J

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

  19. Czupryniak, L

    • Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care December 1999 22:2097-2099; doi:10.2337/diacare.22.12.2097

D

  1. Daniel, M

    • Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care December 1999 22:1993-1998; doi:10.2337/diacare.22.12.1993

  2. Doi, K

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  3. Donner, T W

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

  4. Drzewoski, J

    • Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents. Diabetes Care December 1999 22:2097-2099; doi:10.2337/diacare.22.12.2097

  5. Dunger, D B

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

E

  1. Edmonds, M E

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  2. Elian, N

    • Safety of human insulin in poor-sighted elderly diabetic patients. Diabetes Care December 1999 22:2089; doi:10.2337/diacare.22.12.2089b

F

  1. Fairburn, C G

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

  2. Feldman, S

    • Safety of human insulin in poor-sighted elderly diabetic patients. Diabetes Care December 1999 22:2089; doi:10.2337/diacare.22.12.2089b

  3. Fernlund, P

    • Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care December 1999 22:1944-1949; doi:10.2337/diacare.22.12.1944

  4. Ford, E S

    • Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care December 1999 22:1971-1977; doi:10.2337/diacare.22.12.1971
    • Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care December 1999 22:1978-1983; doi:10.2337/diacare.22.12.1978

  5. Forsen, T

    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

  6. Foster, A

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  7. Fotheringham, M J

    • Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care December 1999 22:1933-1937; doi:10.2337/diacare.22.12.1933

  8. Fujibayashi, K

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  9. Fukushima, M

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  10. Fumelli, P

    • Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients. Diabetes Care December 1999 22:2033-2036; doi:10.2337/diacare.22.12.2033

G

  1. Gabriely, I

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  2. Gale, E A

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  3. Gardner, S G

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  4. Gattegno, L

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

  5. Gentile, L

    • Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes. Diabetes Care December 1999 22:2092; doi:10.2337/diacare.22.12.2092b

  6. Gillespie, K M

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  7. Glasgow, R E

    • In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care December 1999 22:2090-2092; doi:10.2337/diacare.22.12.2090

  8. Gonder-Frederick, L A

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

  9. Grande, C

    • Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care December 1999 22:2085-2086; doi:10.2337/diacare.22.12.2085

  10. Groop, P H

    • In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care December 1999 22:2055-2060; doi:10.2337/diacare.22.12.2055

H

  1. Hallmans, G

    • Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care December 1999 22:1988-1992; doi:10.2337/diacare.22.12.1988

  2. Hanley, A J

    • Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care December 1999 22:2095-2096; doi:10.2337/diacare.22.12.2095

  3. Harris, S B

    • Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care December 1999 22:2095-2096; doi:10.2337/diacare.22.12.2095

  4. Hegele, R A

    • Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care December 1999 22:2095-2096; doi:10.2337/diacare.22.12.2095

  5. Heine, R J

    • The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care December 1999 22:2004-2010; doi:10.2337/diacare.22.12.2004

  6. Henricsson, M

    • Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care December 1999 22:1944-1949; doi:10.2337/diacare.22.12.1944

  7. Herranz, L

    • Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care December 1999 22:2085-2086; doi:10.2337/diacare.22.12.2085

  8. Hori, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  9. Horsten, M

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

  10. Hyöty, H

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  11. Hyppönen, E

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

I

  1. Ikegami, H

    • All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care December 1999 22:2094-2095; doi:10.2337/diacare.22.12.2094

  2. Ilonen, J

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  3. Ishikawa, S

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  4. Itabashi, N

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  5. Ito, M K

    • A drug interaction between troglitazone and simvastatin. Diabetes Care December 1999 22:2104-2106; doi:10.2337/diacare.22.12.2104a

  6. Iwasaki, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

J

  1. James, R W

    • Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients. Diabetes Care December 1999 22:2033-2036; doi:10.2337/diacare.22.12.2033

  2. Janez, M

    • Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care December 1999 22:2085-2086; doi:10.2337/diacare.22.12.2085

  3. Jansen, H

    • Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care December 1999 22:2083-2084; doi:10.2337/diacare.22.12.2083

  4. Javorski, W C

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  5. Jick, S S

    • Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care December 1999 22:2067-2071; doi:10.2337/diacare.22.12.2067

  6. Johnston, G D

    • Relationship of endothelial function to birth weight in humans. Diabetes Care December 1999 22:2061-2066; doi:10.2337/diacare.22.12.2061

  7. Julian, D M

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

K

  1. Kaplan, J

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  2. Karvonen, M

    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

  3. Kataoka, K

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  4. Kawakami, A

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  5. Kenward, M G

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

  6. Kishimoto, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  7. Klein, B E

    • Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care December 1999 22:1984-1987; doi:10.2337/diacare.22.12.1984

  8. Klein, R

    • Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care December 1999 22:1984-1987; doi:10.2337/diacare.22.12.1984

  9. Knip, M

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950
    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961
    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  10. Kodama, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  11. Ko, G T

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  12. Komulainen, J

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  13. Kovatchev, B P

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

  14. Kulmala, P

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  15. Kusaka, I

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

L

  1. Lawrence, K E

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  2. Li, J K

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  3. Lindahl, B

    • Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care December 1999 22:1988-1992; doi:10.2337/diacare.22.12.1988

  4. Lin, J C

    • A drug interaction between troglitazone and simvastatin. Diabetes Care December 1999 22:2104-2106; doi:10.2337/diacare.22.12.2104a

  5. Lipsky, M S

    • The short-term impact of a continuing medical education program on providers' attitudes toward treating diabetes. Diabetes Care December 1999 22:1929-1932; doi:10.2337/diacare.22.12.1929

  6. Lizzio, S

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  7. Loi, CM

    • Response to Lin and Ito. Effect of troglitazone on atorvastatin pharmacokinetics and pharmacodynamics Diabetes Care 22:2105-2106; doi:10.2337/diacare.22.12.2105

  8. Lönnrot, M

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  9. Lord, M

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  10. Lormeau, B

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

  11. Lounamaa, R

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  12. Lu, F H

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

  13. Lynch, J

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

M

  1. Marciulionyte, D

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  2. Matsuhisa, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  3. Mayou, R A

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

  4. McAllister, A S

    • Relationship of endothelial function to birth weight in humans. Diabetes Care December 1999 22:2061-2066; doi:10.2337/diacare.22.12.2061

  5. McCance, D R

    • Relationship of endothelial function to birth weight in humans. Diabetes Care December 1999 22:2061-2066; doi:10.2337/diacare.22.12.2061

  6. McDermott, R

    • Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care December 1999 22:1993-1998; doi:10.2337/diacare.22.12.1993

  7. Melki, V

    • Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs. Diabetes Care December 1999 22:2089-2090; doi:10.2337/diacare.22.12.2089a

  8. Mendlowitz, D

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  9. Mevorach, M

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  10. Michalik, D

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  11. Miki, T

    • All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care December 1999 22:2094-2095; doi:10.2337/diacare.22.12.2094

  12. Mittleman, M A

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

  13. Miwa, K

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  14. Moline, N

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  15. Moore, W P

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  16. Moss, S E

    • Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care December 1999 22:1984-1987; doi:10.2337/diacare.22.12.1984

  17. Motz, E

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  18. Myers, M W

    • Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care December 1999 22:2067-2071; doi:10.2337/diacare.22.12.2067

  19. Mylvaganam, A

    • Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care December 1999 22:1993-1998; doi:10.2337/diacare.22.12.1993

N

  1. Nagasaka, S

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  2. Nagata, I

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  3. Nakai, Y

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  4. Nakamura, T

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  5. Neil, A

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

O

  1. O'Dea, K

    • Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care December 1999 22:1993-1998; doi:10.2337/diacare.22.12.1993

  2. Ogihara, T

    • All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care December 1999 22:2094-2095; doi:10.2337/diacare.22.12.2094

  3. Onkamo, P

    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

  4. Oranje, W A

    • Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care December 1999 22:2083-2084; doi:10.2337/diacare.22.12.2083

  5. Orth-Gomér, K

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

  6. Ozaki, H

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

P

  1. Pallardo, F

    • Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care December 1999 22:2085-2086; doi:10.2337/diacare.22.12.2085

  2. Peveler, R C

    • Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care December 1999 22:1956-1960; doi:10.2337/diacare.22.12.1956

  3. Piitulainen, A

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

  4. Pinzur, M S

    • American Orthopaedic Foot and Ankle Society diabetic shoe survey. Diabetes Care December 1999 22:2099-2100; doi:10.2337/diacare.22.12.2099a

  5. Pitei, D L

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  6. Podar, T

    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

  7. Pouwer, F

    • The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care December 1999 22:2004-2010; doi:10.2337/diacare.22.12.2004

R

  1. Rahko, J

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  2. Rassam, A G

    • Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care December 1999 22:2037-2043; doi:10.2337/diacare.22.12.2037

  3. Reijonen, H

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  4. Roller, S

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  5. Rondas-Colbers, G J

    • Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care December 1999 22:2083-2084; doi:10.2337/diacare.22.12.2083

  6. Rowley, K G

    • Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study. Diabetes Care December 1999 22:1993-1998; doi:10.2337/diacare.22.12.1993

  7. Russo, A

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

S

  1. Sadur, C N

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  2. Saito, T

    • Troglitazone efficacy in a subject with glucocorticoid-induced diabetes. Diabetes Care December 1999 22:2088-2089; doi:10.2337/diacare.22.12.2088

  3. Sakai, M

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  4. Savola, K

    • Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1950-1955; doi:10.2337/diacare.22.12.1950

  5. Sawyer, M

    • Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care December 1999 22:1933-1937; doi:10.2337/diacare.22.12.1933

  6. Schade, D S

    • Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care December 1999 22:2037-2043; doi:10.2337/diacare.22.12.2037

  7. Schenck-Gustafsson, K

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

  8. Sedman, AJ

    • Response to Lin and Ito. Effect of troglitazone on atorvastatin pharmacokinetics and pharmacodynamics Diabetes Care 22:2105-2106; doi:10.2337/diacare.22.12.2105

  9. Selby, J V

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  10. Selmo, V

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  11. Seppälä-Lindroos, A

    • In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care December 1999 22:2055-2060; doi:10.2337/diacare.22.12.2055

  12. Shamoon, H

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  13. Sharp, L K

    • The short-term impact of a continuing medical education program on providers' attitudes toward treating diabetes. Diabetes Care December 1999 22:1929-1932; doi:10.2337/diacare.22.12.1929

  14. Sirolla, C

    • Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients. Diabetes Care December 1999 22:2033-2036; doi:10.2337/diacare.22.12.2033

  15. Snoek, F J

    • The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care December 1999 22:2004-2010; doi:10.2337/diacare.22.12.2004

  16. Sobhy, T A

    • Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care December 1999 22:2037-2043; doi:10.2337/diacare.22.12.2037

  17. Stender, M

    • Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care December 1999 22:2067-2071; doi:10.2337/diacare.22.12.2067

  18. Sundkvist, G

    • Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables. Diabetes Care December 1999 22:1944-1949; doi:10.2337/diacare.22.12.1944

  19. Swain, B E

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  20. Swennen, G N

    • Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care December 1999 22:2083-2084; doi:10.2337/diacare.22.12.2083

T

  1. Taboga, C

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  2. Tani, A

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  3. Taniguchi, A

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  4. Taylor, J

    • Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes. Diabetes Care December 1999 22:1933-1937; doi:10.2337/diacare.22.12.1933

  5. Tokuyama, K

    • Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance. Diabetes Care December 1999 22:2100-2101; doi:10.2337/diacare.22.12.2100

  6. Tonutti, L

    • Meal-generated oxidative stress in diabetes. The protective effect of red wine. Diabetes Care December 1999 22:2084-2085; doi:10.2337/diacare.22.12.2084

  7. Tsang, L W

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  8. Tuomilehto, J

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961
    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

  9. Tuomilehto-Wolf, E

    • Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group. Diabetes Care December 1999 22:2092-2094; doi:10.2337/diacare.22.12.2092a

U

  1. Ueda, N

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  2. Urbonaite, B

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

V

  1. Valensi, P

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

  2. van der Ploeg, H M

    • The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes. Diabetes Care December 1999 22:2004-2010; doi:10.2337/diacare.22.12.2004

  3. Vaysse, J

    • Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients. Diabetes Care December 1999 22:2044-2048; doi:10.2337/diacare.22.12.2044

  4. Vehkavaara, S

    • In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care December 1999 22:2055-2060; doi:10.2337/diacare.22.12.2055

  5. Vice, P A

    • Insulin lispro, pregnancy, and retinopathy. Diabetes Care December 1999 22:2101-2104; doi:10.2337/diacare.22.12.2101

  6. Vilja, P

    • Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care December 1999 22:2086-2088; doi:10.2337/diacare.22.12.2086

  7. Virta-Autio, P

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

  8. Virtanen, S M

    • Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care December 1999 22:1961-1965; doi:10.2337/diacare.22.12.1961

W

  1. Wägner, A M

    • Benzodiazepine interruption. Does it cause hypoglycemia? Diabetes Care December 1999 22:2099; doi:10.2337/diacare.22.12.2099b

  2. Wamala, S P

    • Education and the metabolic syndrome in women. Diabetes Care December 1999 22:1999-2003; doi:10.2337/diacare.22.12.1999

  3. Watkins, P J

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  4. Watson, R

    • Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care December 1999 22:2011-2017; doi:10.2337/diacare.22.12.2011

  5. Webb, S M

    • Benzodiazepine interruption. Does it cause hypoglycemia? Diabetes Care December 1999 22:2099; doi:10.2337/diacare.22.12.2099b

  6. Weinehall, L

    • Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care December 1999 22:1988-1992; doi:10.2337/diacare.22.12.1988

  7. Weitzman, S

    • Impaired fasting glucose is not a risk factor for cardiovascular mortality. Diabetes Care December 1999 22:2104; doi:10.2337/diacare.22.12.2104b

  8. Westerbacka, J

    • In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care December 1999 22:2055-2060; doi:10.2337/diacare.22.12.2055

  9. Williams, A J

    • Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care December 1999 22:2049-2054; doi:10.2337/diacare.22.12.2049

  10. Wilson, S

    • Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot. Diabetes Care December 1999 22:1966-1970; doi:10.2337/diacare.22.12.1966

  11. Wolffenbuttel, B H

    • Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care December 1999 22:2083-2084; doi:10.2337/diacare.22.12.2083

  12. Wozniak, R

    • Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. Diabetes Care December 1999 22:2026-2032; doi:10.2337/diacare.22.12.2026

  13. Wu, C H

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

  14. Wu, J S

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

Y

  1. Yamada, K

    • All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care December 1999 22:2094-2095; doi:10.2337/diacare.22.12.2094

  2. Yamamoto, M

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  3. Yamasaki, Y

    • Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes. Diabetes Care December 1999 22:2072-2077; doi:10.2337/diacare.22.12.2072

  4. Yao, W J

    • Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution. Diabetes Care December 1999 22:1938-1943; doi:10.2337/diacare.22.12.1938

  5. Yeung, V T

    • Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese. Diabetes Care December 1999 22:2096-2097; doi:10.2337/diacare.22.12.2096

  6. Yki-Järvinen, H

    • In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care December 1999 22:2055-2060; doi:10.2337/diacare.22.12.2055

  7. Yoneda, H

    • All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes. Diabetes Care December 1999 22:2094-2095; doi:10.2337/diacare.22.12.2094

  8. Young-Hyman, D L

    • Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia. Diabetes Care December 1999 22:2018-2025; doi:10.2337/diacare.22.12.2018

Z

  1. Zeise, T M

    • Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care December 1999 22:2037-2043; doi:10.2337/diacare.22.12.2037

  2. Zinman, B

    • Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care December 1999 22:2095-2096; doi:10.2337/diacare.22.12.2095

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement